309 related articles for article (PubMed ID: 9637713)
1. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.
Rodrigues CM; Fan G; Ma X; Kren BT; Steer CJ
J Clin Invest; 1998 Jun; 101(12):2790-9. PubMed ID: 9637713
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation.
Rodrigues CM; Ma X; Linehan-Stieers C; Fan G; Kren BT; Steer CJ
Cell Death Differ; 1999 Sep; 6(9):842-54. PubMed ID: 10510466
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes.
Azzaroli F; Mehal W; Soroka CJ; Wang L; Lee J; Crispe IN; Boyer JL
Hepatology; 2002 Jul; 36(1):49-54. PubMed ID: 12085348
[TBL] [Abstract][Full Text] [Related]
5. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid and in vitro vasoactivity of hydrophobic bile acids.
Bomzon A; Ljubuncic P
Dig Dis Sci; 2001 Sep; 46(9):2017-24. PubMed ID: 11575458
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells.
Im E; Martinez JD
J Nutr; 2004 Feb; 134(2):483-6. PubMed ID: 14747693
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling.
Im E; Akare S; Powell A; Martinez JD
Nutr Cancer; 2005; 51(1):110-6. PubMed ID: 15749637
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CYP [correction of CXP] and preservation of BSEP activities.
Paolini M; Pozzetti L; Montagnani M; Potenza G; Sabatini L; Antelli A; Cantelli-Forti G; Roda A
Hepatology; 2002 Aug; 36(2):305-14. PubMed ID: 12143038
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells.
Abdel-Latif MM; Inoue H; Reynolds JV
Eur J Cancer Prev; 2016 Sep; 25(5):368-79. PubMed ID: 26378497
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
Castro RE; Amaral JD; Solá S; Kren BT; Steer CJ; Rodrigues CM
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G327-34. PubMed ID: 17431217
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes.
Sola S; Ma X; Castro RE; Kren BT; Steer CJ; Rodrigues CM
J Biol Chem; 2003 Dec; 278(49):48831-8. PubMed ID: 14514686
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro.
Zhu L; Shan LJ; Liu YJ; Chen D; Xiao XG; Li Y
J Dig Dis; 2014 Dec; 15(12):684-93. PubMed ID: 25214410
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells.
Shah SA; Volkov Y; Arfin Q; Abdel-Latif MM; Kelleher D
Int J Cancer; 2006 Feb; 118(3):532-9. PubMed ID: 16106402
[TBL] [Abstract][Full Text] [Related]
16. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis.
Amaral JD; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Biol Chem; 2007 Nov; 282(47):34250-9. PubMed ID: 17881359
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
Lim SC; Choi JE; Kang HS; Han SI
Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.
Botla R; Spivey JR; Aguilar H; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 1995 Feb; 272(2):930-8. PubMed ID: 7853211
[TBL] [Abstract][Full Text] [Related]
19. Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice.
Yamamoto M; Miura N; Ohtake N; Amagaya S; Ishige A; Sasaki H; Komatsu Y; Fukuda K; Ito T; Terasawa K
Gastroenterology; 2000 Feb; 118(2):380-9. PubMed ID: 10648466
[TBL] [Abstract][Full Text] [Related]
20. Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes.
Solá S; Amaral JD; Castro RE; Ramalho RM; Borralho PM; Kren BT; Tanaka H; Steer CJ; Rodrigues CM
Hepatology; 2005 Oct; 42(4):925-34. PubMed ID: 16175607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
